Clinical Trials Browser

Phase 3 × Head and Neck Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00412217 2016-11-25

A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer

Phase 3 Terminated

94 enrolled 6 charts

Head and Neck Neoplasms